Sartorius acquires WaterSep BioSeparations

By The Science Advisory Board staff writers

December 11, 2020 -- Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023 of up to $9 million. The transaction adds to Sartorius' filtration units for bioprocessing devices.

WaterSep BioSeparations is a privately owned company based in Malborough, MA, which employs 15 people and is on track to earn revenue of approximately $2.5 million in 2020. The company develops, manufactures, and markets hollow-fiber membrane devices (crossflow filtration) and presterilized assemblies for upstream and downstream biopharmaceutical applications.
Sartorius expands small sample filtration to 50mL
The new Sartolab RF 50 vacuum filtration units are available in two versions, one with an asymmetric 0.22 µm PES membrane for sterile filtration...

Copyright © 2020 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter